- Ardelt, W., K. Shogen, and Z. Darzynkiewicz. 2008. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Current Pharmaceutical Biotechnology, 9(3):215-225.
- Barnard, E. 1969. Biological Function of Pancreatic Ribonuclease. Nature, 221: 340- 344.
- Becker, R. R., J. L. Halbrook, and C. Hirs.. 1973. Isolation and Characterization of Ovine Ribonuclease A, B, and C from Pancreatic Secretion. Journal of Biological Chemistry, 248:7826-7832.
- Breukelman, H. J., N. Munnik, and R. Kleineidam. 1998. Secretory ribonuclease genes and pseudogenes in true ruminants. Gene, 212(2):259-68.
- J. J., and J. M. van der Laan. 1986. Comparison of the structure of turtle pancreatic ribonuclease with those of mammalian ribonuclease. The Federation of European Biochemical Societies, 194(2):338–343.
- Claudi, M., M. Cuchillo, R. Victòria Nogués, and T. Raines. 2011. Bovine Pancreatic Ribonuclease: 50 Years of the First Enzymatic Reaction Mechanism. The Journal of Biochemistry, 50(37):7835–7841.
- De Lorenzo, C., A. Nigro, R. Piccoli, and G. D'Alessio. 2002. A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cells. The Federation of European Biochemical Societies, 516(1-3):208-212.
- De Lorenzo, C., A. Arciello, R. Cozzolino, D. B. Palmer, P. Laccetti, R. Piccoli, and G. D'Alessio. 2004. A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomas. Cancer Research, 64(14):4870-4874.
- DelCardayr, S. B., M. Ribio, E. M. Yokel, D. J. Quirk, W. J. Rutter and R. T. Ruines. 1995. Engineering ribonuclease A: Production, purification and characterization of wild-type enzyme and mutants at Glnll. Protein Engineering, 18:261-273.
- Forouharmehr, A., M. Nassiri, S. Ghovvati, and A. Javadmanesh. 2020. Production and introduction of a novel immunotoxin based on mutant RNase A for inducing death to Her1‐positive cell lines. Journal of Cell Physiology, doi: 10.1002/jcp.29346
- Forouharmehr, A., M. Nassiri, S. Ghovvati, and A. Javadmanesh, A. 2018. Different Signal Peptides for Secretory Production of Recombinant Bovine Pancreatic Ribonuclease A in Gram Negative Bacterial System: An In silico Study. Current Proteomics, 15: 24-31
- R. F., and J. Atkins. 1993. The RNA World. Cold SpringHarbor LaboratoryPress Plainview, NY.
- Ghovvati, S. 2014. Engineering ScFv-FC antibody bound to RNase to target HER2 antigen. Doctoral dissertation, Ferdowsi University. (In Persian)
- He, F. 2011. Bradford Protein Assay. Biotechnology Innovation Organization, 101:e45. 10.21769.45.
- Jaydarian, A., N. Nazifi, and A. Forouharmehr. 2020. Computational design of a novel multi-epitope vaccine against Coxiella burnetii. Human Immunology, 10:10-16.
- Leich, F., N. Stohr, A. Rietz, R. Ulbrich-Hofmann, and U. Arnold. 2007. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases. Journal of Biological Chemistry, 282(38):27640-27646.
- Lomax, J. E., C. M. Bianchetti, A. Chang, G. N. Phillips, B. G. Fox, and R. T. Raines. 2014. Functional evolution of ribonuclease inhibitor: insights from birds and reptiles. Journal of Molecular Biology, 426(17):3041‐3056.
- Lu, L., J. Li, M. Moussaoui, and E. Boix. 2018. Immune Modulation by Human Secreted RNases at the Extracellular Space. Frontiers in Immunology, 9:1012.
- Menzel, C., T. Schirrmann, Z. Konthur, T. Jostock, and S. Dubel. 2008. Human antibody RNase fusion protein targeting CD30+ lymphomas. Blood, 111(7):3830-3837.
- Merlino, A., L. Mazzarella, A. Carannante, A. Di Fiore, A. Di Donato, E. Notomista, and F. Sica. 2005. The importance of dynamic effects on the enzyme activity: X-ray structure and molecular dynamics of onconase mutants. The Journal of Biological Chemistry, 6;280(18):17953-60.
- Pikkemaat, M. G., B. M. Linssen, J. C. Berendsen, and D. B. Janssen. 2002. Molecular dynamics 355 simulations as a tool for improving protein stability. Protein Engineering, Design and Selection, 15:185–192.
- Raines, R. T. 1998. Ribonuclease A. Chemical Review, 98:1045-1065.
- Riccio, G., C. D. Avino, R. T. Raines, C. D. Lorenzo. 2013. A novel fully human antitumor ImmunoRNase resistant to the RNase inhibitor. Protein Engineering, Design & Selection, 26:243–248.
- Rutkoski, T. J., and R. T. Raines. 2008. Evasion of ribonuclease inhibitor as a determinant of 360 ribonuclease cytotoxicity. Current Pharmaceutical Biotechnology, 9(3):185-9.
- Sells, , J. Li, and J. Chernoff. 1995. Delivery of proteins into cells using cationic liposomes. BioTechniques, 19(1):72-6.
- Stigh, E., G. Aqvist, and C. B. Anfinsen. 1958. The Isolation and Characterization of Ribonucleases from Sheep Pancreas. The Journal of Biological Chemistry, 234:1112-1117.
- Schirrmann, T., J. Krauss, M. A. Arndt, S. M. Rybak, and S. Dubel. 2009. Targeted therapeutic RNases (ImmunoRNases). Expert Opinion on Biological Therapy, 9(1):79-95.
- Schmid, F., and H. Blaschek. 1984. An early intermediate in the folding of ribonuclease A is protected against cleavage by pepsin. Biochemistry, 23(10):2128‐2133.
- Sundlass, N. K., and R. T. Raines. 2011. Arginine residues are more effective than lysine residues in eliciting the cellular uptake of onconase. Biochemistry, 50(47):10293-9.
- Turcotte, R. F., L. D. Lavis, and R. T. Raines. 2009. Onconase cytotoxicity relies on the distribution of its positive charge. The Federation of European Biochemical Societies, 276(14):3846-3857.
- Tripathy, D. R., A. K. Dinda, A. K., and Dasgupta, S. 2013. A simple assay for the ribonuclease activity of ribonucleases in the presence of ethidium bromide. Analytical Biochemistry, 437(2):126-9.
- http://www.uniprot.org
- Welling, G., Scheffer, A., and Beintema, J. 1974. The Primary structure of goat and sheep pancreatic ribonucleases. North-Holland Publishing Company – Amsterdam,41:58- 61.
- Zeiske, T., Stafford, K. A., and Palmer, A. G. 2016. Thermostability of Enzymes from Molecular Dynamics Simulations. Journal of Chemical Theory and Computation, 14;12(6):2489-92
|
2؛ علی جوادمنش